PVP Ventures Limited (PVP) fundamentals
PVP Ventures Limited is a listed company in Realty, part of the Realty sector, listed on the NSE as PVP (ISIN INE362A01016). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
What PVP Ventures Limited does
PVP Ventures Limited is an India-based company, which is engaged in the business of health care services and developing urban infrastructure and investments in various ventures. The Company’s segments include Real Estate, Health Care Services and Others. It offers healthcare services across a spectrum of offerings driven entirely through inorganic growth. Its focus areas include cancer care, senior care, teleradiology, dialysis, and diagnostics, including genomics. The Company’s brands include Orange Imaging & Diagnostics, DOC Medical Services and Humain Sai Labs. Its subsidiaries include PVP Corporate Parks Private Limited, Safetrunk Services Private Limited, Humain Healthtech Private Limited, Noble Diagnostics Private Limited and Apta Medical Imaging Private Limited.
Valuation and market data
| Last close | ₹64.82 |
|---|---|
| Market capitalisation | ₹2,483 crore |
| Enterprise value | ₹2,682 crore |
| P/E (TTM) | 0.00 |
| Price to book | 6.25 |
| Price to sales (TTM) | 12.46 |
| Book value per share | ₹10.37 |
| Dividend yield | 0.00% |
| Sector | Realty |
| Industry | Realty |
| Listed since | Wed Apr 03 |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹53 crore | ₹1 crore | ₹1 crore | 0.03 |
| Mar 2025 | ₹28 crore | ₹-5 crore | ₹-4 crore | -0.15 |
| Mar 2024 | ₹8 crore | ₹28 crore | ₹32 crore | 1.28 |
| Mar 2023 | ₹160 crore | ₹62 crore | ₹38 crore | 1.55 |
| Mar 2022 | ₹33 crore | ₹-502 crore | ₹-502 crore | -20.50 |
Figures are as reported (standalone), in ₹ crore.
Shareholding pattern
As of Jun 2026:
| Promoters | 61.3% |
|---|---|
| Foreign institutions (FII) | 0.1% |
| Mutual funds | 0.0% |
| Other domestic institutions | 0.0% |
| Retail and others | 38.6% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.